There has been a small incidence of diffuse clotting, especially in atypical body sites, like the central vein draining the brain, among some AstraZeneca and J&J COVID-19 vaccine recipients. A newly released pre-print suggests a possible underlying biologic cause.
Phase III trials put the efficacy of the two earliest COVID-19 vaccines in the mid-’90s, certainly more than we had hoped. The word on the media “street” has been that vaccinations result in fewer hospitalizations and no deaths. The CDC is now reporting on “breakthrough infections” since the beginning of the year.
Ever heard of the Hotze Health & Wellness Center in Houston? If not, you're better off. Its founder, Dr. Steven Hotze, has plenty to say about COVID, almost all of it completely wrong.
There's a new vaccine in town and all the nut logs and screwballs are blabbering nonsense rumors all over the Internet. Here's one that is especially bad – that the Pfizer/Moderna COVID vaccines can give you COVID. No, they can't. It is physically impossible. Here's why.
We know we develop an immune response to COVID-19 if we are infected or vaccinated, but just how long does it last? The answer to that question is becoming more evident.
By any measure, today's announcement about the unexpected efficacy of the Pfizer/BioNTech coronavirus vaccine is great news. But, Pfizer's Dr. Robert Popovian cautions us that the job is not done. There are policies that are essential to ensure the vaccine is promoted to the public, distributed, and administered properly. And be priced so that everyone can get it. Devil. Details.
There have been several significant developments in recent days regarding the ongoing COVID-19 pandemic and the hunt for a successful vaccine. We discuss some of them below.
Operation Warp Speed is the name of the federal effort to quickly bring a COVID-19 vaccine to the public. Like all federal efforts, it carries both a price tag and an organizational chart.
Just as COVID-19 is a global problem, the search for a vaccine is a global effort. Sometimes, to get clarity, especially in the run-up to a presidential election, it is better to get an outsider's view.
As the possibility of a vaccine for COVID-19 draws nearer, so does the consideration of who is "first" in line to receive it. Should we protect the vulnerable, like the elderly, or reduce the spread by prioritizing "superspreaders"? More importantly, beyond this utilitarian consideration are there additional ethical concerns? Let's take a look.
Dr. Paul Offit, Chief of Infectious Diseases and Director of the Vaccine Education Center at Children’s Hospital of Philadelphia, discusses COVID-19 vaccines with Eric Topol, MD, Editor-in-Chief of the website, Medscape. From safety to side effects, to how protective they might be.
What happens when politics and science mix? Scary stuff. Dr. Henry Miller examines the considerable downside of releasing any COVID vaccine prior to the completion of Phase 3 trials. The founding director of the FDA's Office of Biotechnology, Dr. Miller argues that precise science, not the date of an election, is critical at this time.